3-D Matrix, EBIT

3-D Matrix,'s ebit stands at $2.6B as of July 2026. That compares with $-1.4B in the prior-year period — up 287.0% year over year. That is below the Healthcare sector average of $130B. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

3-D Matrix, reported $2.6B in EBIT versus $-1.4B a year earlier — a 287.0% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

3-D Matrix, sits lower the Healthcare benchmark ($130B) with a EBIT of $2.6B. That is roughly 98.1% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

That compares with $-1.4B in the prior-year period — up 287.0% year over year. Sustained growth in EBIT can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how 3-D Matrix,'s EBIT evolved across reporting periods, while the comparison chart places DMTRF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.